Finding microplastic contamination in rare sarcomas in 20-30 yo patients is unserious. Got it. Thanks for clarifying.
November 1, 2026 at 5:54 PM
Finding microplastic contamination in rare sarcomas in 20-30 yo patients is unserious. Got it. Thanks for clarifying.
Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs. https://www.biorxiv.org/content/10.64898/2026.10.28.762504v1
October 29, 2026 at 9:49 PM
Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs. https://www.biorxiv.org/content/10.64898/2026.10.28.762504v1
Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs. https://www.biorxiv.org/content/10.64898/2026.10.28.762504v1
October 29, 2026 at 9:49 PM
Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs. https://www.biorxiv.org/content/10.64898/2026.10.28.762504v1
Cancer-free margins just 1 millimeter wide may be enough for certain soft tissue sarcomas in young patients, potentially sparing healthy tissue. Tumor size and other treatments still matter. doi.org/hcqmxz
Wider surgical margins may not mean better cancer control
It's a question that surgeons often face: How much surrounding healthy tissue should they take out when removing a patient's cancer to be sure it is fully eliminated?
medicalxpress.com
October 28, 2026 at 10:20 PM
Cancer-free margins just 1 millimeter wide may be enough for certain soft tissue sarcomas in young patients, potentially sparing healthy tissue. Tumor size and other treatments still matter. doi.org/hcqmxz
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
News update via NF Bot
bsky.app
October 29, 2026 at 10:40 AM
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
#SJORANM #Radiology #NuclearMedicine
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
#SJORANM #Radiology #NuclearMedicine
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Swiss J. Radiol. Nucl. Med. · Vol. 15 No. 1 · 2025-01-29 · DOI doi.org/10.59667/sjoranm.v15i1.12 · Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves. These tumors are associated with neurofibromatosis type 1 (NF1), and…
sjoranm.com
October 28, 2026 at 7:27 PM
Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
#SJORANM #Radiology #NuclearMedicine
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas arising from the peripheral nerves…
📄 PDF: sjoranm.com/sjoranm/article/download/49/48
#SJORANM #Radiology #NuclearMedicine
When both of my dogs were diagnosed with sarcomas, I was surprised to discover the appalling state of veterinary oncology. Having worked for pharma and biotech companies with large oncology TAs and comparative medicine groups, it was surprising to discover that the Medicines that were at one point
It started with Lily the French bulldog's brain tumor. Now this Bay Area startup is ready to take into the clinic its first cancer drug for dogs www.bizjournals.com/sanfrancisco...
Lily the French bulldog’s brain tumor spurred these biotech veterans to launch a startup - San Francisco Business Times
After Lily the French bulldog was diagnosed with a brain tumor, these biotech veterans flew into action with a startup now prepping its first clinical trial.
www.bizjournals.com
October 27, 2026 at 7:29 PM
When both of my dogs were diagnosed with sarcomas, I was surprised to discover the appalling state of veterinary oncology. Having worked for pharma and biotech companies with large oncology TAs and comparative medicine groups, it was surprising to discover that the Medicines that were at one point
#IOVA Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ES…
https://www.stocktitan.net/news/IOVA/iovance-announces-data-showing-durable-responses-with-lifileucel-til-k53e588t501d.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IOVA/iovance-announces-data-showing-durable-responses-with-lifileucel-til-k53e588t501d.html?utm_source=stocktitan-bluesky&utm_medium=social
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 26, 2026 at 11:00 AM
#IOVA Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ES…
https://www.stocktitan.net/news/IOVA/iovance-announces-data-showing-durable-responses-with-lifileucel-til-k53e588t501d.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IOVA/iovance-announces-data-showing-durable-responses-with-lifileucel-til-k53e588t501d.html?utm_source=stocktitan-bluesky&utm_medium=social
Iovance annonce à l'ESMO 2026 des données démontrant des réponses durables avec la thérapie cellulaire Lifileucel TIL dans les sarcomes des tissus mous avancés
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
50% Confirmed Objective Response Rate (ORR) with All Responses Ongoing in an Oral Presentation at the European Society for Medical Oncology (ESMO) Congress...
www.globenewswire.com
October 26, 2026 at 7:57 PM
Iovance annonce à l'ESMO 2026 des données démontrant des réponses durables avec la thérapie cellulaire Lifileucel TIL dans les sarcomes des tissus mous avancés
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
More from #ESMO2026!
VHIO researchers are sharing their expertise in scientific and educational sessions, contributing to discussions across different areas of oncology.
Great to see Alejandra Rezqallah, Judith Balmaña and Cristina Suárez taking part!
VHIO researchers are sharing their expertise in scientific and educational sessions, contributing to discussions across different areas of oncology.
Great to see Alejandra Rezqallah, Judith Balmaña and Cristina Suárez taking part!
October 25, 2026 at 8:56 PM
More from #ESMO2026!
VHIO researchers are sharing their expertise in scientific and educational sessions, contributing to discussions across different areas of oncology.
Great to see Alejandra Rezqallah, Judith Balmaña and Cristina Suárez taking part!
VHIO researchers are sharing their expertise in scientific and educational sessions, contributing to discussions across different areas of oncology.
Great to see Alejandra Rezqallah, Judith Balmaña and Cristina Suárez taking part!
Récemment publié
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas (RPS)
Lignes directrices pratiques complètes du CAR/CSAR concernant l'imagerie, la biopsie, le suivi et la prise de décision clinique dans le cadre des sarcomes rétropéritonéaux.
🔗 https://bit.ly/4yYTuOi
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas (RPS)
Lignes directrices pratiques complètes du CAR/CSAR concernant l'imagerie, la biopsie, le suivi et la prise de décision clinique dans le cadre des sarcomes rétropéritonéaux.
🔗 https://bit.ly/4yYTuOi
October 23, 2026 at 2:58 PM
Récemment publié
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas (RPS)
Lignes directrices pratiques complètes du CAR/CSAR concernant l'imagerie, la biopsie, le suivi et la prise de décision clinique dans le cadre des sarcomes rétropéritonéaux.
🔗 https://bit.ly/4yYTuOi
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas (RPS)
Lignes directrices pratiques complètes du CAR/CSAR concernant l'imagerie, la biopsie, le suivi et la prise de décision clinique dans le cadre des sarcomes rétropéritonéaux.
🔗 https://bit.ly/4yYTuOi
Please help if you can. My Zeus is only 6, he needs urgent immediately for aggressive Sarcomas. STS’s surgery is booked for November 6th at 8:00am
gofund.me/7de74c38d
gofund.me/7de74c38d
October 23, 2026 at 10:27 PM
Please help if you can. My Zeus is only 6, he needs urgent immediately for aggressive Sarcomas. STS’s surgery is booked for November 6th at 8:00am
gofund.me/7de74c38d
gofund.me/7de74c38d
NOW PUBLISHED 📝
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas
Comprehensive CAR/CSAR practice guidelines for retroperitoneal sarcoma imaging, biopsy, multidisciplinary management, staging, surveillance, and clinical decision-making.
https://bit.ly/4yYTuOi
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas
Comprehensive CAR/CSAR practice guidelines for retroperitoneal sarcoma imaging, biopsy, multidisciplinary management, staging, surveillance, and clinical decision-making.
https://bit.ly/4yYTuOi
October 23, 2026 at 2:34 PM
NOW PUBLISHED 📝
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas
Comprehensive CAR/CSAR practice guidelines for retroperitoneal sarcoma imaging, biopsy, multidisciplinary management, staging, surveillance, and clinical decision-making.
https://bit.ly/4yYTuOi
CAR/CSAR Practice Guideline on Retroperitoneal Sarcomas
Comprehensive CAR/CSAR practice guidelines for retroperitoneal sarcoma imaging, biopsy, multidisciplinary management, staging, surveillance, and clinical decision-making.
https://bit.ly/4yYTuOi
We've recently held Spotlight on Sarcoma Days in Stanmore and Leeds!
140 healthcare professionals came together to hear from sarcoma specialists and patients, sharing knowledge to improve care.
Thank you to everyone involved in helping raise awareness and support earlier diagnosis!
140 healthcare professionals came together to hear from sarcoma specialists and patients, sharing knowledge to improve care.
Thank you to everyone involved in helping raise awareness and support earlier diagnosis!
October 21, 2026 at 4:00 PM
We've recently held Spotlight on Sarcoma Days in Stanmore and Leeds!
140 healthcare professionals came together to hear from sarcoma specialists and patients, sharing knowledge to improve care.
Thank you to everyone involved in helping raise awareness and support earlier diagnosis!
140 healthcare professionals came together to hear from sarcoma specialists and patients, sharing knowledge to improve care.
Thank you to everyone involved in helping raise awareness and support earlier diagnosis!
🔬 Pediatric cancers like sarcomas urgently need better treatment options.
With a #CaixaImpulse Innovation grant, Josep Roma (@vhir.bsky.social) redesigns a compound blocking the Hedgehog pathway to improve its stability, reduce side effects & fight tumor growth. 👇
https://tinyurl.com/466x2tke
With a #CaixaImpulse Innovation grant, Josep Roma (@vhir.bsky.social) redesigns a compound blocking the Hedgehog pathway to improve its stability, reduce side effects & fight tumor growth. 👇
https://tinyurl.com/466x2tke
October 19, 2026 at 1:13 PM
🔬 Pediatric cancers like sarcomas urgently need better treatment options.
With a #CaixaImpulse Innovation grant, Josep Roma (@vhir.bsky.social) redesigns a compound blocking the Hedgehog pathway to improve its stability, reduce side effects & fight tumor growth. 👇
https://tinyurl.com/466x2tke
With a #CaixaImpulse Innovation grant, Josep Roma (@vhir.bsky.social) redesigns a compound blocking the Hedgehog pathway to improve its stability, reduce side effects & fight tumor growth. 👇
https://tinyurl.com/466x2tke
Teen's death inspires mum's drive for earlier rare cancer diagnosis
www.bbc.com/news/article...
www.bbc.com/news/article...
Stratford teen's death inspires mum's drive for earlier rare cancer diagnosis
Hannah York hopes new guidance will help doctors spot signs of soft tissue sarcomas sooner.
www.bbc.com
October 18, 2026 at 12:09 PM
Teen's death inspires mum's drive for earlier rare cancer diagnosis
www.bbc.com/news/article...
www.bbc.com/news/article...
Teen's death inspires mum's drive for earlier rare cancer diagnosis www.bbc.co.uk/news/article...
Stratford teen's death inspires mum's drive for earlier rare cancer diagnosis
Hannah York hopes new guidance will help doctors spot signs of soft tissue sarcomas sooner.
www.bbc.co.uk
October 18, 2026 at 12:55 AM
Teen's death inspires mum's drive for earlier rare cancer diagnosis www.bbc.co.uk/news/article...
RRIDs were included in this in Advanced Science paper. RRIDs improve reproducibility in scientific research. #OpenScience #OpenResearch #accelerateopenscience
A Living Multi‐Omics PDX Biobank of High‐Risk Sarcomas Reveals ecDNA‐Driven Oncogene Amplification in Osteosarcoma and Enables Preclinical Precision Oncology
Read the full paper: A Living Multi‐Omics PDX Biobank of High‐Risk Sarcomas Reveals ecDNA‐Driven Oncogene Amplification in Osteosarcoma and Enables Preclinical Precision Oncology
doi.org
October 16, 2026 at 7:00 AM
RRIDs were included in this in Advanced Science paper. RRIDs improve reproducibility in scientific research. #OpenScience #OpenResearch #accelerateopenscience
Happy to share our article! We built a biobank of 155 PDX models across 11 sarcoma subtypes, revealing ecDNA-driven oncogene amplification in osteosarcoma—with MYC ecDNA linked to aggressive disease. PDX models retain ecDNA, mirror patient tumors, and enable genotype-matched targeted therapy.
A Living Multi‐Omics PDX Biobank of High‐Risk Sarcomas Reveals ecDNA‐Driven Oncogene Amplification in Osteosarcoma and Enables Preclinical Precision Oncology
A living multi-omics sarcoma PDX biobank is enriched for high-risk disease and preserves key patient tumor features at histopathological and molecular levels. Integrated profiling reveals ecDNA-drive...
advanced.onlinelibrary.wiley.com
October 16, 2026 at 1:41 PM
Happy to share our article! We built a biobank of 155 PDX models across 11 sarcoma subtypes, revealing ecDNA-driven oncogene amplification in osteosarcoma—with MYC ecDNA linked to aggressive disease. PDX models retain ecDNA, mirror patient tumors, and enable genotype-matched targeted therapy.
Malignant peripheral nerve sheath tumors are rare, aggressive soft tissue sarcomas. Hirbe & team show dual inhibition with FAK and RAF/MEK in mice overcomes resistance, suppresses growth, and induces tumor regression in chromosome 8 gain MPNST: doi.org/10.1172/JCI2...
@sargoshoe.bsky.social
@sargoshoe.bsky.social
October 14, 2026 at 12:03 PM
Malignant peripheral nerve sheath tumors are rare, aggressive soft tissue sarcomas. Hirbe & team show dual inhibition with FAK and RAF/MEK in mice overcomes resistance, suppresses growth, and induces tumor regression in chromosome 8 gain MPNST: doi.org/10.1172/JCI2...
@sargoshoe.bsky.social
@sargoshoe.bsky.social
O Talentiño reunirá música y solidaridad en Canido con un festival benéfico contra el cáncer
La recaudación se destinará a dos entidades dedicadas a la lucha contra el cáncer, entre ellas ASARGA, especializada en sarcomas
La recaudación se destinará a dos entidades dedicadas a la lucha contra el cáncer, entre ellas ASARGA, especializada en sarcomas
O Talentiño Solidario: festival contra el cáncer en Canido
O Talentiño organiza un festival solidario contra el cáncer el 8 de noviembre en Canido, con música, sorteos y entrada voluntaria a beneficio de dos entidades.
eldepartamental.es
October 15, 2026 at 2:15 PM
O Talentiño reunirá música y solidaridad en Canido con un festival benéfico contra el cáncer
La recaudación se destinará a dos entidades dedicadas a la lucha contra el cáncer, entre ellas ASARGA, especializada en sarcomas
La recaudación se destinará a dos entidades dedicadas a la lucha contra el cáncer, entre ellas ASARGA, especializada en sarcomas
Rachel M Hurley, Hesham Mohei, and Malay Haldar
TIME to Target Sarcomas: Lessons from the Tumor Immune Microenvironment
The tumor immune microenvironment (TIME) has emerged as a crucial regulator of antitumor immune responses with important therapeutic, prognostic, and predictive implications. Despite the success of immunotherapies in select solid tumors, notably melanoma and non-small cell lung cancer, their impact in soft-tissue sarcomas (STSs) is limited, often attributed to an immune-cold TIME passively driven by low neoantigen burden. Herein, we review the current understanding of the STS TIME, its...
www.annualreviews.org
October 14, 2026 at 11:00 PM
Rachel M Hurley, Hesham Mohei, and Malay Haldar